Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development

Hasonló tételek

• Pegylation and formulation strategy of Anti-Microbial Peptide (AMP) according to the quality by design approach
  Szerző: Manteghi Reihaneh, et al.
  Megjelent: (2020)
• Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach.
  Szerző: Bartos Csilla, et al.
  Megjelent: (2018)
• Quality by Design driven development of Liraglutide loaded nanocarrier system designed for oral delivery
  Szerző: Ismail Ruba, et al.
  Megjelent: (2019)
• Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs
  Szerző: Ismail Ruba, et al.
  Megjelent: (2017)
• Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation
  Szerző: Pallagi Edina, et al.
  Megjelent: (2015)